Wells Fargo raised the firm’s price target on Mesa Labs (MLAB) to $94 from $83 and keeps an Equal Weight rating on the shares. The firm notes the company posted a solid beat on Q3 revenue and adjusted EBITDA, with strong margin expansion despite foreign-exchange headwinds. With numbers moving up, leverage down and management taking more shareholder-friendly steps, there’s more room for valuation to re-rate, in Wells’ view.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MLAB:
